Klaria Pharma Holding AB (publ.) (STO:KLAR)
0.7880
+0.0080 (1.03%)
Jul 24, 2026, 5:24 PM CET
STO:KLAR Revenue
Klaria Pharma Holding AB (publ.) had revenue of 101.00K SEK in the quarter ending March 31, 2026, a decrease of -98.88%. This brings the company's revenue in the last twelve months to 115.00K, down -98.97% year-over-year. In the year 2025, Klaria Pharma Holding AB (publ.) had annual revenue of 9.03M with 288.31% growth.
Revenue (ttm)
115.00K
Revenue Growth
-98.97%
P/S Ratio
1,938.29
Revenue / Employee
25.00K
Employees
4
Market Cap
193.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.03M | 6.71M | 288.31% |
| Dec 31, 2024 | 2.33M | 2.10M | 920.18% |
| Dec 31, 2023 | 228.00K | -6.31M | -96.51% |
| Dec 31, 2022 | 6.54M | -30.98M | -82.58% |
| Dec 31, 2021 | 37.52M | 29.52M | 369.16% |
| Dec 31, 2020 | 8.00M | -3.59M | -30.97% |
| Dec 31, 2019 | 11.59M | 10.76M | 1,309.37% |
| Dec 31, 2018 | 822.00K | -1.83M | -68.95% |
| Dec 31, 2017 | 2.65M | 2.29M | 639.39% |
| Dec 31, 2016 | 358.00K | 46.00K | 14.74% |
| Dec 31, 2015 | 312.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 432.66M |
| Cinclus Pharma Holding AB | 67.51M |
| Cereno Scientific AB | 66.82M |
| Nanexa AB | 54.41M |
| Enzymatica AB | 51.93M |
| Newbury Pharmaceuticals AB | 35.02M |
| Orexo AB | 16.60M |
| Moberg Pharma AB | 14.59M |
Klaria Pharma Holding AB (publ.) News
- 2 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q1 2026 - Filings
- 5 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q4 2025 - Filings
- 5 months ago - Klaria Pharma Holding AB (publ.) Annual report: Q4 2025 - Filings
- 8 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q3 2025 - Filings
- 11 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q2 2025 - Filings